A probability-based approach for predicting HIV infection in a low prevalent population of injection drug users

被引:7
作者
Cheng, FK [1 ]
Ford, WL [1 ]
Weber, MD [1 ]
Cheng, SY [1 ]
Kerndt, PR [1 ]
机构
[1] UNIV CALIF LOS ANGELES,DEPT MATH,LOS ANGELES,CA 90024
关键词
HIV; probability model; IDUs; low HIV seroprevalence; IDU risk score; IDU risk behaviors;
D O I
10.1016/S1047-2797(96)00108-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article proposes a method for estimating HIV risk in low-HIV-prevalent populations. Allard's risk probability model was used to compute individual risk scores. Based on a sample of 3854 injection drug users (IDUs) who were confidentially tested for HN at five methadone treatment clinics in Los Angeles County, the following self-reported risk behaviors were used to derive an individual IDU risk score: (i) frequency of injection, (ii) frequency of wing uncleaned needles, (iii) number of people sharing a needle, (iv) frequency of needle sharing, and (v) type of needle sharing practice. The overall HIV prevalence for the IDU sample was 2%. The risk score was strongly associated with HIV seropositivity (chi-square 16.1, P < 0.0001), but only one of the individual IDU risk behaviors (needle cleaning) was significantly associated with HIV seropositivity (chi-square = 10.9, P < 0.001). In addition, the risk score was strongly associated with HN serostatus for both males and females. For females, however, none of the individual IDU risk behaviors were associated with HIV serostatus. Our findings indicate indicate that when predicting HIV infection in a low-prevalence population, the probability-based risk score makes a statistically significant contribution over individual IDU risk behaviors. (C) 1991 by Elsevier Science Inc.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 12 条
[1]  
ALLARD R, 1990, J ACQ IMMUN DEF SYND, V3, P1010
[2]  
BATTJES RJ, 1989, J ACQ IMMUN DEF SYND, V2, P533
[3]   COCAINE USE AND HIV INFECTION IN INTRAVENOUS DRUG-USERS IN SAN-FRANCISCO [J].
CHAISSON, RE ;
BACCHETTI, P ;
OSMOND, D ;
BRODIE, B ;
SANDE, MA ;
MOSS, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (04) :561-565
[4]   RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AMONG PARENTERAL DRUG-ABUSERS IN A LOW-PREVALENCE AREA [J].
CHANDRASEKAR, PH ;
MOLINARI, JA ;
KRUSE, JA .
SOUTHERN MEDICAL JOURNAL, 1990, 83 (09) :996-1001
[5]  
FORD WL, 1992, HIV 1 SEROINCIDENCE
[6]   RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION AMONG OUT-OF-TREATMENT DRUG INJECTORS IN HIGH AND LOW SEROPREVALENCE CITIES [J].
FRIEDMAN, SR ;
JOSE, B ;
DEREN, S ;
JARLAIS, DCD ;
NEAIGUS, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (08) :864-874
[7]   RISK FOR OCCUPATIONAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ASSOCIATED WITH CLINICAL-EXPOSURES - A PROSPECTIVE EVALUATION [J].
HENDERSON, DK ;
FAHEY, BJ ;
WILLY, M ;
SCHMITT, JM ;
CAREY, K ;
KOZIOL, DE ;
LANE, HC ;
FEDIO, J ;
SAAH, AJ .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (10) :740-746
[8]  
MARMOR M, 1987, AIDS, V1, P39
[9]   RISK-FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN INTRAVENOUS DRUG-USERS [J].
SCHOENBAUM, EE ;
HARTEL, D ;
SELWYN, PA ;
KLEIN, RS ;
DAVENNY, K ;
ROGERS, M ;
FEINER, C ;
FRIEDLAND, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (13) :874-879
[10]   HIV-INFECTION AND RISK BEHAVIORS AMONG INTRAVENOUS-DRUG-USERS IN LOW SEROPREVALENCE AREAS IN THE MIDWEST [J].
SIEGAL, HA ;
CARLSON, RG ;
FALCK, R ;
LI, L ;
FORNEY, MA ;
RAPP, RC ;
BAUMGARTNER, K ;
MYERS, W ;
NELSON, M .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1991, 81 (12) :1642-1644